Medicine and Dentistry
Fatty Acid
52%
Type 2 Diabetes
33%
Insulin Signaling
23%
Acipimox
23%
Plasma
23%
Muscle
14%
Serositis
9%
Phosphorylation
9%
Glucose
9%
Insulin Sensitivity
9%
Ceramide
9%
Species
9%
Protein
4%
Toxicity
4%
Pathogenesis
4%
Gene Expression
4%
Skeletal Muscle
4%
Insulin Resistance
4%
Alternative Complement Pathway C3 C5 Convertase
4%
Nuclear Factor
4%
Phosphotransferase
4%
Monocyte Chemotactic Protein 1
4%
Toll Like Receptor 4
4%
Myositis
4%
Drug
4%
Chemotherapeutic Agent
4%
Protein C Jun
4%
Gene
4%
Neuroscience
Free Fatty Acids
100%
Insulin Signaling
23%
Insulin
23%
Acipimox
23%
Phosphorylation
9%
Glucose
9%
Diglyceride
9%
Ceramide
9%
Alternative Complement Pathway C3 C5 Convertase
4%
Monocyte Chemotactic Protein 1
4%
Nuclear Factor
4%
TLR 4
4%
Kinase
4%
Skeletal Muscle
4%
Gene Expression
4%
Gene
4%
Protein
4%
Protein C Jun
4%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Acid
52%
Insulin
23%
Acipimox
23%
Human
9%
Glucose
9%
Diacylglycerol
9%
Ceramide
9%
Protein
4%
Phosphotransferase
4%
Toxicity
4%
Insulin Resistance
4%
Pathogenesis
4%
Drug
4%
Alternative Complement Pathway C3 C5 Convertase
4%
Nuclear Factor
4%
Monocyte Chemotactic Protein 1
4%
Protein C Jun
4%
Toll Like Receptor 4
4%
Myositis
4%
Biochemistry, Genetics and Molecular Biology
Reduction (Chemistry)
28%
Insulin
23%
Insulin Signaling
23%
Fatty Acid Blood Level
19%
Phosphorylation
9%
Glucose
9%
Human
9%
Insulin Sensitivity
9%
Ceramide
9%
Species
9%
Skeletal Muscle
4%
Nested Gene
4%
Gene Expression
4%
Kinase
4%
Insulin Resistance
4%
Protein C Jun
4%